| Annexin A5 as a targeting agent for cancer treatment A Woodward, GNF Faria, RG Harrison Cancer Letters 547, 215857, 2022 | 27 | 2022 |
| Controlling nanoparticle uptake in innate immune cells with heparosan polysaccharides W Yang, AN Frickenstein, V Sheth, A Holden, EM Mettenbrink, L Wang, ... Nano letters 22 (17), 7119-7128, 2022 | 20 | 2022 |
| Immunogenic Treatment of Metastatic Breast Cancer Using Targeted Carbon Nanotube Mediated Photothermal Therapy in Combination with Anti-Programmed Cell Death Protein-1 GNF Faria, CG Karch, S Chakraborty, T Gu, A Woodward, A Aissanou, ... The Journal of Pharmacology and Experimental Therapeutics 390 (1), 65-77, 2024 | 3 | 2024 |
| Anionic phospholipid expression as a molecular target in Listeria monocytogenes and Escherichia coli P McKernan, B Cassidy, A Woodward, J Battiste, D Drevets, R Harrison International Journal of Antimicrobial Agents 56 (6), 106183, 2020 | 3 | 2020 |
| Annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer A Woodward, B Southard, S Chakraborty, AO Bailey, GNF Faria, ... Molecular Biomedicine 5 (1), 7, 2024 | 1 | 2024 |
| Targeted Protein-Drug Conjugate for the Treatment of Triple-Negative Breast Cancer A Woodward, B Southard, S Chakraborty, A Bailey, W Raqaq, R Harrison 2024 AIChE Annual Meeting, 2024 | | 2024 |
| Novel protein drug conjugate ANXV-chemo and cytotoxic and anti-proliferative effects against human triple-negative breast cancer in vitro. AA Woodward, K Potrzebowska, S Suchdev, A Thibault, A Frostegård, ... Journal of Clinical Oncology 42 (16_suppl), e15024-e15024, 2024 | | 2024 |
| Correction: annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer A Woodward, B Southard, S Chakraborty, AO Bailey, GNF Faria, ... Molecular Biomedicine 5 (1), 16, 2024 | | 2024 |
| Translation and Development of Novel Annexin A5-Protein Drug Conjugates for the Treatment of Triple-Negative Breast Cancer A Woodward | | 2022 |
| Carbon Nanotube-Protein Conjugate for Photothermal Therapy Combined with Checkpoint Inhibition for the Immunomodulatory Treatment of Metastatic Breast Cancer G Faria, CG Karch, A Aissanou, A Woodward, R Harrison 2022 AIChE Annual Meeting, 2022 | | 2022 |
| Annexin A5-DM1 Protein Drug Conjugate Combined with Immune Stimulation and mTOR Inhibitor Treatment of Triple-Negative Breast Cancer A Woodward, G Faria, B Southard, R Harrison 2021 AIChE Annual Meeting, 2021 | | 2021 |
| Evaluating Parameters Associated with the Activation of Immune Response in Phosphatidylserine Targeted Photothermal Therapy of Triple Negative Breast Cancer Tumor Model in Mice G Faria, CG Karch, A Woodward, A Aissanou, P McKernan, R Harrison 2021 AIChE Annual Meeting, 2021 | | 2021 |
| Anionic phospholipid expression as a molecular target in Listeria monocytogenes and Escherichia coli (vol 56, 106183, 2020) P McKernan, B Cassidy, A Woodward, J Battiste, D Drevets, R Harrison INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 58 (5), 2021 | | 2021 |
| Corrigendum to" Anionic phospholipid expression as a molecular target in Listeria monocytogenes and Escherichia coli"[International Journal of Antimicrobial Agents, Volume 56 … P McKernan, B Cassidy, A Woodward, J Battiste, D Drevets, R Harrison International journal of antimicrobial agents 58 (5), 106423, 2021 | | 2021 |
| Novel Cytostatic Annexin A5-Drug Conjugates for Cancer Treatment B Southard, P McKernan, A Woodward, R Harrison 2019 AIChE Annual Meeting, 2019 | | 2019 |
| Patient navigation core metrics before and after implementation of a nurse navigation program at CHI St. Francis Cancer Treatment Center: A community based cancer program. MS Copur, M McDonald, Y Zhou, V Hurley, A Tasa, C Johnson, R Evans, ... Journal of Clinical Oncology 35 (15_suppl), e18040-e18040, 2017 | | 2017 |
